A Study to Evaluate the Efficacy and Safety of Herceptin (Trastuzumab) in Combination With an Aromatase Inhibitor in Patients With Metastatic Breast Cancer
This study is ongoing, but not recruiting participants.
Study NCT00022672
Information provided by Hoffmann-La Roche
First Received: August 10, 2001
Last Updated: September 16, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
